Prevention of neural tube defects: Vitamins, enzymes and genes

Current Opinion in Neurology

Volumn 11, Issue 2, 1998, Pages 97-102

  Copp, Andrew J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; FOLIC ACID; HOMOCYSTEINE; INOSITOL; VITAMIN;

ANIMAL MODEL; EMBRYO DEVELOPMENT; HUMAN; METABOLIC DISORDER; NEURAL TUBE DEFECT; NEURULATION; NONHUMAN; REVIEW;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ANIMALS; CYSTATHIONINE BETA-SYNTHASE; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; INOSITOL; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MICE; MICE, NEUROLOGIC MUTANTS; NEURAL TUBE DEFECTS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PREGNANCY; VITAMINS;

EID: 0031921685     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199804000-00003     Document Type: Review

References (74)

1. Elwood JM, Elwood JH. Epidemiology of anencephalus and spina bifida. Oxford: Oxford University Press; 1980.
2. Chan A, Robertson EF, Haan EA, Keane RJ, Ranieri E, Carney A. Prevalence of neural tube defects in South Australia, 1966-91: effectiveness and impact of prenatal diagnosis. Br Med J 1993; 307:703-706.
3. Roberts HE, Moore CA, Cragan JD, Fernhoff PM, Khoury MJ. Impact of prenatal diagnosis on the birth prevalence of neural tube defects, Atlanta, 1990-1991. Pediatrics 1995; 96:880-883.
4. Janerich DT. Epidemic waves in the prevalence of anencephaly and spina bifida in New York State. Teratology 1973; 8:253-256.
5. Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC, Harris R, et al. Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child 1981; 56:911-918.
6. Scott JM, Kirke PN, Weir DG. The role of nutrition in neural tube defects. Annu Rev Nutr 1990; 10:277-295.
7. Wald N, Sneddon J, Densem J, Frost C, Stone R, MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338:131-137.
8. Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327:1832-1835.
9. Krischer J. Knowledge about folic acid and the prevention of neural tube defects in two general practice populations. Br J Gen Pract 1997; 47:231-232. This questionnaire study shows a persisting lack of awareness, particularly among women in an inner-city area, of the link between folic acid supplementation and prevention of neural tube defects.
10. Clark NAC, Fisk NM. Minimal compliance with the Department of Health recommendation for routine folate prophylaxis to prevent fetal neural tube defects. Br J Obstet Gynaecol 1994; 101:709-710.
11. Milner M, Slevin J, Morrow A, Fawzy M, Clarke T, McKenna P. Suboptimal compliance with periconceptual folic acid in an Irish hospital population. Ir Med J 1996; 89:28-30.
12. Campbell NRC. How safe are folic acid supplements. Arch Intern Med 1996; 156:1638-1644.
13. Scott JM, Weir DG, Molloy A, McPartlin J, Daly L, Kirke P. Folic acid metabolism and mechanisms of neural tube defects. In: Bock G, Marsh J (editors): Neural tube defects (Ciba Foundation Symposium 181). Chichester: John Wiley & Sons; 1994. pp. 180-187.
14. Bower C, Stanley FJ, Croft M, De Klerk NH, Davis RE, Nicol DJ. Absorption of pteroylpolyglutamates in mothers of infants with neural tube defects. Br J Nutr 1993; 69:827-834.
15. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, Eskes TKAB. Neural-tube defects and derangement of homocysteine metabolism. N Engl J Med 1991; 324:199-200.
16. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995; 345:149-151.
17. Rosenquist TH, Ratashak SA, Selhub J. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci USA 1996; 93:15227-15232.
18. VanAerts LAGJM, Blom HJ, Deabreu RA, Trijbels FJM, Eskes TKAB, Peereboom-Stegeman JHJC, et al. Prevention of neural tube defects by and toxicity of L-homocysteine in cultured postimplantation rat embryos. Teratology 1994; 50:348-360.
19. 12 are independent risk factors for neural tube defects. Q J Med 1993; 86:703-708.
20. •].
21. •] are the first papers to describe the structure of the methionine synthase gene, a candidate for mutation in neural tube defects.
22. Morrison K, Edwards YH, Lynch SA, Burn J, Hol F, Mariman E. Methionine synthase and neural tube defects. J Med Genet 1997; 34:958.
23. Van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FJM, Eskes TKAB, Van den Heuvel LP, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346:1070-1071.
24. Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, et al. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 1995; 88:763-766.
25. De Franchis R, Sebastio G, Mandato C, Andria G, Mastroiacovo P. Spina bifida, 677T → C mutation, and role of folate. Lancet 1995; 346:1703.
26. Wilcken DEL, Wang XL. Relevance to spina bifida of mutated methylenetetrahydrofolate reductase. Lancet 1996; 347:340.
27. Papapetrou C, Lynch SA, Burn J, Edwards YH. Methylenetetrahydrofolate reductase and neural tube defects. Lancet 1996; 348:58.
28. Van der Put NMJ, Eskes TKAB, Blom HJ. Is the common 677C → T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. Q J Med 1997; 90:111-115. A meta-analysis of worldwide data on allele frequencies in the MTHFR gene support an association of the thermolabile allele with predisposition to neural tube defect.
29. Ramsbottom D, Scott JM, Molloy A, Weir DG, Kirke PN, Mills JL, et al. Are common mutations of cystathionine beta-synthase involved in the aetiology of neural tube defects? Clin Genet 1997; 51:39-42.
30. Neumann PE, Frankel WN, Letts VA, Coffin JM, Copp AJ, Bernfield M. Multifactorial inheritance of neural tube defects: localization of the major gene and recognition of modifiers in ct mutant mice. Nature Genet 1994; 6:357-362.
31. Letts VA, Schork NJ, Copp AJ, Bernfield M, Frankel WN. Mapping modifier genes for tail defects in curly-tail mutant mice. Genomics 1995; 29:719-724.
32. Seller MJ. Vitamins, folio acid and the cause and prevention of neural tube efects. In: Bock G, Marsh J (editors): Neural tube defects (Ciba Foundation Symposium 181). Chichester: John Wiley & Sons; 1994. pp. 161-173.
33. Van Straaten HWM, Blom H, Peeters MCE, Rousseau AMJ, Cole KJ, Seller MJ. Dietary methionine does not reduce penetrance in curly tail mice but causes a phenotype-specific decrease in embryonic growth. J Nutr 1995; 125:2733-2740.
34. Hunt SM, Groff JL. Advanced nutrition and human metabolism. St. Paul: West Publishing Company; 1990.
35. Greene NDE, Copp AJ. Inositol prevents folate-resistant neural tube defects in the mouse. Nature Med 1997; 3:60-66. Myo-inositol is demonstrated to prevent spinal defects in a mouse genetic model of folate-resistant neural tube defects.
36. Cockroft DL. Changes with gestational age in the nutritional requirements of postimplantation rat embryos in culture. Teratology 1988; 38:281-290.
37. Zhao Q, Behringer RR, De Crombrugghe B. Prenatal folic acid treatment suppresses acrania and meroanencephaly in mice mutant for the Cart1 homeobox gene. Nature Genet 1996; 13:275-283.
38. Essien FB, Wannberg SL. Methionine but not folinic acid or vitamin B-12 alters the frequency of neural tube defects in Axdmutant mice. J Nutr 1993; 123:27-34.
39. Schorle H, Meier P, Buchert M, Jaenisch R, Mitchell PJ. Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature 1996; 381:235-238.
40. Zhang J, Hagopian-Donaldson S, Serbedzija G, Elsemore J, Plehn-Dujowich D, McMahon AP, et al. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature 1996; 381:238-241.
41. Meehan RR, Barlow DP, Hill RE, Hogan BLM, Hastie ND. Pattern of serum protein gene expression in mouse visceral yolk sac and foetal liver. EMBO J 1984; 3:1881-1885.
42. Homanics GE, Smith TJ, Zhang SH, Lee D, Young SG, Maeda N. Targeted modification of the apolipoprotein B gene results in hypobetalipoproteinemia and developmental abnormalities in mice. Proc Natl Acad Sci USA 1993; 90:2389-2393.
43. Essien FB, Haviland MB, Naidoff AE. Expression of a new mutation (Axd) causing axial defects in mice correlates with maternal phenotype and age. Teratology 1990; 42:183-194.
44. Johnson DR. The interfrontal bone and mutant genes in the mouse. J Anat 1976; 121:507-513.
45. Ewart JL, Cohen MF, Meyer RA, Huang GY, Wessels A, Gourdie RG, et al. Heart and neural tube defects in transgenic mice overexpressing the Cx43 gap junction gene. Development 1997; 124:1281-1292.
46. Kalter H. Experimental teratological studies with the mouse CNS mutations cranioschisis and delayed splotch. J Craniofac Genet Dev Biol 1985; (suppl 1):339-342.
47. Morgan W. A new crooked-tail mutation involving distinct pleiotropism. J Genet 1954; 52:354-373.
48. Gruneberg H. Genetical studies on the skeleton of the mouse. VIII. Curly tail. J Genet 1954; 52:52-67.
49. Wallace ME, Knights PJ, Anderson JR. Inheritance and morphology of exencephaly, a neonatal recessive with partial penetrance, in the house mouse. Genet Res 1978; 32:135-149.
50. Schimmang T, Lemaistre M, Vortkamp A, Rüther U. Expression of the zinc finger gene Gli3 is affected in the morphogenetic mouse mutant extra-toes (Xt). Development 1992; 116:799-804.
51. J mutation contains an intragenic deletion of the Gli3 gene. Nature Genet 1993; 3:241-246.
52. Deng CX, Bedford M, Li CL, Xu XL, Yang X, Dunmore J, et al. Fibroblast growth factor receptor-1 (FGFR-1) is essential for normal neural tube and limb development. Dev Biol 1997; 185:42-54.
53. Ishibashi M, Ang S-L, Shiota K, Nakanishi S, Kageyama R, Guillemot F. Targeted disruption of mammalian hairy and Enhancer of split homolog-1 (HES-1) leads to up-regulation of neural helix-loop-helix factors, premature neurogenesis, and severe neural tube defects. Genes Dev 1995; 9:3136-3148.
54. Lufkin T, Dierich A, LeMeur M, Mark M, Chambon P. Disruption of the Hox-1.6 homeobox gene results in defects in a region corresponding to its rostral domain of expression. Cell 1991; 66:1105-1119.
55. Takeuchi T, Yamazaki Y, Katoh-Fukui Y, Tsuchiya R, Kondo S, Motoyama J, Higashinakagawa T. Gene trap capture of a novel mouse gene, jumonji, required for neural tube formation. Genes Dev 1995; 9:1211-1222.
56. Strong LC, Hollander WF. Hereditary loop-tail in the house mouse. J Hered 1949; 40:329-334.
57. Stanier P, Henson JN, Eddleston J, Moore GE, Copp AJ. Genetic basis of neural tube defects: the mouse gene loop-tail maps to a region of Chromosome 1 syntenic with human 1q21-22. Genomics 1995; 26:473-478.
58. Stumpo DJ, Bock CB, Tuttle JS, Blackshear PJ. MARCKS deficiency in mice leads to abnormal brain development and perinatal death. Proc Natl Acad Sci USA 1995; 92:944-948.
59. Wu M, Chen DF, Sasaoka T, Tonegawa S. Neural tube defects and abnormal brain development in F52-deficient mice. Proc Natl Acad Sci USA 1996; 93:2110-2115.
60. Chen J, Chang S, Duncan SA, Okano HJ, Fishell G, Aderem A. Disruption of the MacMARCKS gene prevents cranial neural tube closure and results in anencephaly. Proc Natl Acad Sci USA 1996; 93:6275-6279.
61. Günther T, Struwe M, Aguzzi A, Schughart K. Open brain, a new mouse mutant with severe neural tube defects, shows altered gene expression patterns in the developing spinal cord. Development 1994; 120:3119-3130.
62. Schmid P, Lorenz A, Hameister H, Montenarh M. Expression of p53 during mouse embryogenesis. Development 1991; 113:857-865.
63. Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT, Jacks T. A subset of p53-deficient embryos exhibit exencephaly. Nature Genet 1995; 10:175-180.
64. Morrison-Graham K, Schatteman GC, Bork T, Bowen-Pope DF, Weston JA. A PDGF receptor mutation in the mouse (Patch) perturbs the development of a non-neuronal subset of neural crest-derived cells. Development 1992; 115:133-142.
65. Orr-Urtreger A, Bedford MT, Do M-S, Eisenbach L, Lonai P. Developmental expression of the a receptor for platelet-derived growth factor, which is deleted in the embryonic lethal Patch mutation. Development 1992; 115:289-303.
66. Oka C, Nakano T, Wakeham A, De la Pompa JL, Mori C, Sakai T, et al. Disruption of the mouse RBP-Jkappa gene results in early embryonic death. Development 1995; 121:3291-3301.
67. Lohnes D, Mark M, Mendelsohn C, Dolle P, Dierich A, Gorry P, et al. Function of the retinoic acid receptors (RARs) during development. (I) Craniofacial and skeletal abnormalities in RAR double mutants. Development 1994; 120:2723-2748.
68. Theiler K, Stevens LC. The development of rib fusions, a mutation in the house mouse. Am J Anat 1960; 106:171-183.
69. Juriloff DM, MacDonald KB, Harris MJ. Genetic analysis of the cause of exencephaly in the SELH/Bc mouse stock. Teratology 1989; 40:395-405.
70. Goulding MD, Chalepakis G, Deutsch U, Erselius JR, Gruss P. Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J 1991; 10:1135-1147.
71. 2H). a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell 1991; 67:767-774.
72. Chen Z-F, Behringer RR. Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev 1995; 9:686-699.
73. Wilson DB, Wyatt DP. Pathogenesis of neural dysraphism in the mouse mutant vacuolated lens (vI). J Neuropathol Exp Neurol 1986; 45:43-55.
74. Estibeiro JP, Brook FA, Copp AJ. Interaction between splotch (Sp) and curly tail (ct) mouse mutants in the embryonic development of neural tube defects. Development 1993; 119:113-121.